Companies / Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc.
OTC: AURXNUOTCIK 1091596HOUSTON, TX
Financials · FY2017
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Nov 11, 2014 | Aldagen Holdings, LLC 10% owner | Other Other (per filing) | Common Stock | $1.50M | +1.3M +10.64% | 13,206,265 27.28% of shares | low |
| Apr 29, 2022 | Sheedy Charles E 10% owner | Buy Open-market buy | Common Stock | $804.9K | +805K +7.89% | 11,000,000 22.72% of shares | high |
| Nov 28, 2025 | Jorden David Emerson CEO | Sell Open-market sale | Common Stock | $300.0K | -200K -9.32% | 1,946,755 4.02% of shares | medium |
| Dec 19, 2023 | Pittman Scott M. Director | Grant Grant or award | Common Stock | $300.0K | +600K +13.50% | 5,043,345 10.42% of shares | low |
| Dec 30, 2021 | Sheedy Charles E 10% owner | Exercise In-the-money exercise | Common Stock | $286.3K | +1.4M +16.34% | 10,195,132 21.06% of shares | low |
| Dec 30, 2021 | Jorden David Emerson CEO | Exercise Option exercise | Common Stock | $227.5K | +1.1M +114.95% | 2,127,326 4.39% of shares | low |
| Aug 1, 2023 | Pittman Scott M. Director | Grant Grant or award | Common Stock | $200.0K | +100K +2.30% | 4,443,345 9.18% of shares | low |
| Jul 30, 2025 | Sheedy Charles E 10% owner | Buy Open-market buy | Common Stock | $200.0K | +133K +1.17% | 11,570,833 23.90% of shares | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AURX | common | 67059V209 |